The Value of Clinical Trials from a Patient Perspective

Area of Science:

• Oncology
• Clinical Research
• Patient Advocacy

Background:

• Clinical trials are crucial for advancing cancer treatments, yet U.S. adult cancer accrual rates remain low at 2-3%.
• Newly diagnosed patients often lack awareness of clinical trials, their importance, and how to navigate the enrollment process.
• Current approaches to discussing clinical trials can induce fear and mistrust during a critical time for patients.

Purpose of the Study:

• To address the low accrual rates in cancer clinical trials.
• To improve patient understanding and engagement with clinical research.
• To introduce a new, patient-centered approach for breast cancer clinical trial information dissemination.

Main Methods:

• Development of the CTIP Breast Cancer Kit by the Clinical Trials Information Project (CTIP), a nonprofit organization founded by patients and family members.
• Focus on creating clear, accessible information about the value of research studies.
• Emphasis on delivering information in a supportive and caring manner.

Main Results:

• The CTIP Breast Cancer Kit offers a novel approach to patient education and engagement in clinical trials.
• The kit aims to demystify the clinical trial process for patients, families, and friends.
• This initiative seeks to bridge the gap between scientific discovery and patient application.

Conclusions:

• New strategies are needed to make clinical trial information more accessible and understandable to patients.
• Collaboration between cancer patient advocates and researchers can enhance the dissemination of vital research information.
• The CTIP Breast Cancer Kit represents a significant step towards empowering patients and accelerating clinical trial enrollment.